Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple‐negative breast cancer cells-Reference-Cited by-全球学者库

Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple‐negative breast cancer cells

Published:2020-02-15 Issue:2 Volume:147 Page:490-504
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zeng De¹²,Liang Yuan‐Ke³⁴,Xiao Ying‐Sheng²⁵,Wei Xiao‐Long⁶,Lin Hao‐Yu³,Wu Yang²,Bai Jing‐Wen⁷,Chen Min²,Zhang Guo‐Jun⁷⁸^ORCID

Affiliation:

1. Department of Medical OncologyShantou University Medical College Cancer Hospital Shantou China

2. Changjiang Scholar's LaboratoryShantou University Medical College (SUMC) Shantou China

3. Department of Thyroid and Breast Surgerythe First Affiliated Hospital of Shantou University Medical College Shantou China

4. Department of Medical OncologyUniversity of Groningen, University Medical Center Groningen Groningen The Netherlands

5. Department of Thyroid SurgeryShantou Central Hospital Shantou China

6. Department of PathologyCancer Hospital of SUMC Shantou China

7. The Cancer Center and the Department of Breast and Thyroid SurgeryXiang'an Hospital of Xiamen University, School of Medicine, Xiamen University Xiamen Fujian China

8. Fujian Anti‐Cancer Center Fujian China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32911

Reference50 articles.

1. Cancer statistics, 2018

2. Breast cancer chemoresistance: Emerging importance of cancer stem cells

3. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

4. Breast cancer stem cells, EMT and therapeutic targets

5. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ectopic expression of tumor suppressive miR-181c-5p downregulates oncogenic Notch signaling in MDA-MB-231 cells;Pathology - Research and Practice;2024-01

2. A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathway;einstein (São Paulo);2024

3. Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics;Cancer Cell International;2023-12-06

4. A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer;Journal of Advanced Research;2023-12

5. Retraction: Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct down‐regulation of MCAM in triple‐negative breast cancer cells. De Zeng, Yuan‐Ke Liang, Ying‐Sheng Xiao, Xiao‐Long Wei, Hao‐Yu Lin, Yang Wu, Jing‐Wen Bai, Min Chen, Guo‐Jun Zhang. Int J Cancer. 2020 Jul 15;147(2):490‐504;International Journal of Cancer;2023-11-20